Sterne Kessler Goldstein Fox Patrick E Larren

First Page		Document Content
Date: 2006-06-14 10:03:53 Chemistry Clinical pharmacology Pharmaceutical industry Food and Drug Administration Olopatadine Medical prescription New Drug Application Pharmaceutical drug Pharmacology Pharmaceutical sciences Clinical research		Sterne Kessler Goldstein Fox Patrick E Larren Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 473,05 KB Share Document on Facebook

	Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace DocID: 1uvYN - View Document
	Emergency Use: means the use of a test article on a human subject in a life-threatening situation in DocID: 1riMu - View Document
	United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate DocID: 1riEa - View Document
	Microsoft Word - FINAL 10K2014-Cover Page final to print DocID: 1r76P - View Document
	Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTS DocID: 1qZGZ - View Document